Cochlear Bone Anchored Solutions

Oticon Medical Announces FDA Premarket Approval for Neuro Cochlear Implant System to Treat Severe to Profound Sensorineural Hearing Loss

Retrieved on: 
Thursday, June 24, 2021

With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.

Key Points: 
  • With the expansion of its cochlear implant solutions to the US market, Oticon Medical is well positioned to become the worlds leading hearing expert within implantable hearing solutions.
  • People with severe to profound hearing loss in 51 countries already benefit from the Neuro System.
  • View the full release here: https://www.businesswire.com/news/home/20210624005685/en/
    Oticon Medical announces that the US Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the Neuro Cochlear Implant System to treat severe to profound sensorineural hearing loss.
  • The Neuro System is the first new cochlear implant technology to earn FDA premarket approval in more than 20 years.

Cochlear receives FDA clearance of Baha 6 Max, industry's smallest 55 dB sound processor now with direct Android streaming

Retrieved on: 
Monday, March 8, 2021

Cochlear receives FDA clearance of Baha 6 Max, industry's smallest 55 dB sound processor with Apple, Android streaming

Key Points: 
  • Cochlear receives FDA clearance of Baha 6 Max, industry's smallest 55 dB sound processor with Apple, Android streaming
    With a fitting range of up to 55 dB SNHL (sensorineural hearing level) in the same small size as current 45 dB devices1, the Baha 6 Max is the first of its kind: a premium-power bone conduction sound processor designed for powerful hearing performance.
  • The Baha 6 Max is also the first bone conduction sound processor to offer direct streaming from Apple and Android devices.2 Direct streaming from Apple devices has been available in the Baha 5 Sound Processor since 2015.
  • The Baha 6 Max Sound Processor, Baha Fitting Software 6.0 and Baha Smart App are already approved in Canada.
  • The Cochlear Baha 6 Max Sound Processor is compatible with Apple and Android devices.

MED-EL: First Surgeries Ever in Europe with a Totally Implantable Cochlear Implant

Retrieved on: 
Monday, October 19, 2020

On 24 September, the first person in Europe received a novel totally implantable cochlear implant (TICI).

Key Points: 
  • On 24 September, the first person in Europe received a novel totally implantable cochlear implant (TICI).
  • A young man with close to profound hearing loss was the first person in Europe to receive a fully implantable cochlear implant.
  • Totally implantable cochlear implants will be the most innovative and sophisticated technology in the field of hearing solutions.
  • Several more surgeries with the totally implantable cochlear implant will follow in Lige and Munich in the next couple of months as part of the clinical feasibility study.

MED-EL: First Surgeries Ever in Europe with a Totally Implantable Cochlear Implant

Retrieved on: 
Monday, October 19, 2020

On 24 September, the first person in Europe received a novel totally implantable cochlear implant (TICI).

Key Points: 
  • On 24 September, the first person in Europe received a novel totally implantable cochlear implant (TICI).
  • A young man with close to profound hearing loss was the first person in Europe to receive a fully implantable cochlear implant.
  • Totally implantable cochlear implants will be the most innovative and sophisticated technology in the field of hearing solutions.
  • Several more surgeries with the totally implantable cochlear implant will follow in Lige and Munich in the next couple of months as part of the clinical feasibility study.

FDA expedites approval of Cochlear's Remote Check solution for cochlear implants

Retrieved on: 
Tuesday, April 7, 2020

CENTENNIAL, Colo., April 7, 2020 /PRNewswire/ --Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April 2 for its Remote Check solution.

Key Points: 
  • CENTENNIAL, Colo., April 7, 2020 /PRNewswire/ --Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April 2 for its Remote Check solution.
  • Remote Check will ensure that patients receive the best care no matter where life and times like this take us."
  • Products include cochlear implants, bone conduction implants and acoustic implants, which healthcare professionals use to treat a range of moderate to profound types of hearing loss.
  • And always and other trademarks and registered trademarks are the property of Cochlear Limited or Cochlear Bone Anchored Solutions AB.

Bone Conduction Devices Market To Gain Owing To Rising Prevalence Of Permanent Conductive Hearing Loss & Growing Health Awareness Among The Population: Radiant Insights, Inc.

Retrieved on: 
Wednesday, April 24, 2019

Rapid surge in this market is credited to the rising prevalence of permanent conductive hearing loss or mixed hearing loss and high-level of noise pollution.

Key Points: 
  • Rapid surge in this market is credited to the rising prevalence of permanent conductive hearing loss or mixed hearing loss and high-level of noise pollution.
  • Globally, bone conduction devices market is predicted to generate massive revenue over the next five years, providing numerous opportunities for industry participants to invest in research and development of bone conduction devices.
  • Geriatric population is more prone towards hearing loss, thereby driving demand for bone conduction devices in the market.
  • Bone conduction devices, also termed as bone anchored hearing implants, are primarily used by patient suffering from permanent conductive hearing loss or mixed hearing loss.

Bone Conduction Devices Market To Gain Owing To Rising Prevalence Of Permanent Conductive Hearing Loss & Growing Health Awareness Among The Population: Radiant Insights, Inc.

Retrieved on: 
Wednesday, April 24, 2019

Rapid surge in this market is credited to the rising prevalence of permanent conductive hearing loss or mixed hearing loss and high-level of noise pollution.

Key Points: 
  • Rapid surge in this market is credited to the rising prevalence of permanent conductive hearing loss or mixed hearing loss and high-level of noise pollution.
  • Globally, bone conduction devices market is predicted to generate massive revenue over the next five years, providing numerous opportunities for industry participants to invest in research and development of bone conduction devices.
  • Geriatric population is more prone towards hearing loss, thereby driving demand for bone conduction devices in the market.
  • Bone conduction devices, also termed as bone anchored hearing implants, are primarily used by patient suffering from permanent conductive hearing loss or mixed hearing loss.